NSE · STAR
Strides Pharma Science Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#563
of 5,072 stocks
Peak #561 · 21 Sep 2026
Strides Pharma Science Limited is a midcap company in the Healthcare space and has a widely-held ownership base, with promoters at just 28%, draws sizeable foreign institutional interest (28% FII), and is growing revenue modestly.
Market Cap
10,921.58 Cr
P/E Ratio
19.64
P/B Ratio
3.47
ROE
18.24%
ROCE
21.67%
Dividend Yield
0.42%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 1,265.41 Cr | 1,323.47 Cr | 1,194.65 Cr | 1,220.83 Cr |
| Net Profit | 165.49 Cr | 129.28 Cr | 208.12 Cr | 131.52 Cr |
| EPS | 17.02 | 13.77 | 21.93 | 13.84 |
| Operating Profit | 178.26 Cr | 194.59 Cr | 292.18 Cr | 209.06 Cr |
Shareholding pattern
Promoter
27.91%
Public
72.09%
PUBLIC BREAKDOWN
FII
28.39%
DII
15.41%
MF (within DII)
8.73%
Individuals
22.48%
Mutual fund holdings
₹663.62
Cr total
10
Schemes
6
Fund Houses
₹663.62 Cr
Total Exposure
Quant Mutual Fund₹532.69 Cr (80.3%)
Axis Mutual Fund₹75.34 Cr (11.4%)
Aditya Birla Sun Life Mutual Fund₹37.55 Cr (5.7%)
Motilal Oswal Mutual Fund₹17.91 Cr (2.7%)
Groww Mutual Fund₹0.12 Cr (0.0%)
Others₹0.02 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 31 Jul 2026 | Dividend | Dividend - Rs 5 Per Share |
| 22 Jul 2025 | Dividend | Dividend - Rs 4 Per Share |
| 06 Dec 2024 | Other | Demerger |
| 09 Sep 2024 | Dividend | Dividend - Rs 2.50 Per Share |
| 04 Aug 2023 | Dividend | Dividend - Rs 1.50 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.